Teva Pharmaceutical Industries Limited Share Price
Stocks
TEVA
US8816242098
Pharmaceuticals
OTC Markets Traded|
Market Closed -
NYSE
01:30:03 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 37.09 USD | +2.04% |
|
+2.01% | +18.84% |
| 10/09 | Teva Pharmaceutical Prices $4.9 Billion Senior Notes Offering | MT |
| 09/09 | Leerink Partners Initiates Coverage on Teva Pharmaceutical Industries With Outperform Rating, $45 Price Target | MT |
| Market Cap | 4.32TCr 3.73TCr 3.53TCr 3.2TCr 5.99TCr 4,12900Cr 6.03TCr 42TCr 16TCr 2,08200Cr 16TCr 16TCr 6,63100Cr | P/E 2026 * |
53.1x | P/E 2027 * | 21.9x |
|---|---|---|---|---|---|
| Enterprise Value | 5.51TCr 4.75TCr 4.5TCr 4.08TCr 7.64TCr 5,26600Cr 7.7TCr 53TCr 21TCr 2,65500Cr 21TCr 20TCr 8,45700Cr | EV / Sales 2026 * |
3.32x | EV / Sales 2027 * | 3x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| TEVA | Delayed | |
CBOE
| TEVA | Real-time | |
|
Tradegate
| TEV | Real-time | |
|
Boerse Muenchen
| TEV | Real-time | |
|
Deutsche Boerse AG
| TEV | Delayed | |
|
Mexican S.E.
| TEVA N | End-of-day quote | |
|
London S.E.
| 0LER | Delayed | |
|
Wiener Boerse
| TEVA | End-of-day quote | |
|
Börse Stuttgart
| TEV | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | +2.04% | ||
| 1 week | +2.01% | ||
| Current month | +2.88% | ||
| 1 month | +0.95% | ||
| 3 months | +7.10% | ||
| 6 months | +26.59% | ||
| Current year | +18.84% |
| 1 week | 35.42 |  | 37.32 |
| 1 month | 35.42 | | 38.37 |
| Current year | 27.93 | | 38.37 |
| 1 year | 18.21 | | 38.37 |
| 3 years | 8.06 | | 38.37 |
| 5 years | 6.78 | | 38.37 |
| 10 years | 6.07 | | 52.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/08/26 | Sell | Controller/Auditor | -14,445 | 0.0012% | ||
| 21/08/26 | Sell | Director | -415 | 0.0000% | ||
| 17/08/26 | Sell | EVP, Business Development | -18,600 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | +2.01% | +86.10% | +269.79% | 4.32TCr | |
| -0.65% | -2.93% | +47.70% | +86.17% | 99TCr | |
| -0.29% | -3.51% | +49.15% | +62.35% | 64TCr | |
| +0.83% | +0.26% | +17.76% | +72.25% | 45TCr | |
| -0.38% | -3.59% | +30.13% | +35.17% | 34TCr | |
| -0.09% | -13.54% | +13.34% | +24.95% | 26TCr | |
| -0.43% | -2.48% | -0.73% | +9.58% | 25TCr | |
| -1.34% | -13.70% | +36.53% | +44.96% | 20TCr | |
| -3.44% | -7.51% | -20.63% | -59.44% | 19TCr | |
| -0.75% | -4.82% | +25.46% | +87.14% | 18TCr | |
| Average | -0.45% | -5.26% | +28.48% | +63.29% | 35.48TCr | |
| Weighted average by Cap. | -0.47% | -4.37% | +31.63% | +57.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.66TCr 1.43TCr 1.35TCr 1.23TCr 2.3TCr 1,58600Cr 2.32TCr 16TCr 6.18TCr 80TCr 6.23TCr 6.1TCr 2,54700Cr | 1.73TCr 1.49TCr 1.41TCr 1.28TCr 2.4TCr 1,65500Cr 2.42TCr 17TCr 6.45TCr 83TCr 6.5TCr 6.36TCr 2,65700Cr |
| Net income | 127.48Cr 109.94Cr 104.03Cr 94Cr 176.77Cr 12TCr 177.99Cr 1.24TCr 474.69Cr 6.14TCr 478.57Cr 468.16Cr 20TCr | 243.3Cr 209.82Cr 198.55Cr 179.93Cr 337.37Cr 23TCr 339.7Cr 2.36TCr 905.96Cr 12TCr 913.36Cr 893.51Cr 37TCr |
| Net Debt | 1.19TCr 1.03TCr 971.32Cr 880.21Cr 1.65TCr 1,13700Cr 1.66TCr 12TCr 4.43TCr 57TCr 4.47TCr 4.37TCr 1,82600Cr | 865.23Cr 746.14Cr 706.08Cr 639.85Cr 1.2TCr 83TCr 1.21TCr 8.39TCr 3.22TCr 42TCr 3.25TCr 3.18TCr 1,32700Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $37.09 | +2.04% | 28,55,422 |
| 10/26/10 | $36.35 | -1.36% | 40,14,361 |
| 09/26/09 | $36.85 | +0.24% | 39,99,774 |
| 08/26/08 | $36.76 | +1.10% | 46,23,970 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
